quinidine

E852339

Quinidine is an antiarrhythmic medication derived from cinchona bark, primarily used to treat certain types of cardiac arrhythmias.

Try in SPARQL Jump to: Statements Referenced by

Statements (54)

Predicate Object
instanceOf antiarrhythmic agent
class IA antiarrhythmic
pharmaceutical drug
quinoline alkaloid
stereoisomer of quinine
belongsTo World Health Organization list of essential medicines (historically for arrhythmias) NERFINISHED
bindsTo cardiac sodium channels
derivedFrom cinchona bark
discoveredFrom Cinchona species
excretedBy kidney
hasAdverseEffect QT prolongation
cinchonism
diarrhea
headache
hemolytic anemia
hypotension
nausea
thrombocytopenia
tinnitus
torsades de pointes
ventricular tachycardia
hasATCCode C01BA01
hasBioavailability high oral bioavailability
hasCASNumber 56-54-2
hasChEBIID CHEBI:8639
hasChemicalFormula C20H24N2O2
hasContraindication complete heart block
history of torsades de pointes
myasthenia gravis NERFINISHED
hasDrugBankID DB00908
hasHalfLife approximately 6 to 8 hours
hasIUPACName (R)-(6-methoxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol
hasMolarMass 324.42 g/mol
hasPharmacologicalEffect decreases myocardial excitability
slows conduction in the His-Purkinje system
hasPregnancyCategory varies by jurisdiction
hasPubChemCID 441074
hasRouteOfAdministration intravenous
oral
hasUNII ITX08688JL
inhibits CYP2D6
P-glycoprotein NERFINISHED
isOpticalIsomerOf quinine
mechanismOfAction blocks fast inward sodium current in cardiac tissue
prolongs QT interval
prolongs cardiac action potential duration
metabolizedBy CYP2D6 NERFINISHED
CYP3A4 NERFINISHED
usedFor pharmacologic cardioversion of atrial fibrillation
treatment of atrial fibrillation
treatment of atrial flutter
treatment of supraventricular arrhythmias
treatment of ventricular arrhythmias
usedWith digoxin NERFINISHED

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

P-glycoprotein inhibitorOfType quinidine